FDA gives Sorin nod on trial for sutureless aortic valve

05/2/2013 | Clinica (subscription required)

The FDA has given Sorin the OK to start a clinical study of its Perceval S sutureless aortic tissue valve, moving the Italian cardiovascular firm closer to obtaining premarket approval for the product. The trial will involve aortic stenosis patients from as many as 25 clinical sites in the U.S.

View Full Article in:

Clinica (subscription required)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC